Expanding the Spectrum of FAT1 Nephropathies by Novel Mutations That Affect Hippo Signaling
Open Access
- 29 January 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International Reports
- Vol. 6 (5), 1368-1378
- https://doi.org/10.1016/j.ekir.2021.01.023
Abstract
No abstract availableFunding Information
- Deutsche Forschungsgemeinschaft
This publication has 35 references indexed in Scilit:
- Hippo signaling in the kidney: the good and the badAmerican Journal of Physiology-Renal Physiology, 2016
- Genome-Wide Analysis of Wilms’ Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory MechanismsJournal of the American Society of Nephrology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Mutations in NEK8 link multiple organ dysplasia with altered Hippo signalling and increased c-MYC expressionHuman Molecular Genetics, 2013
- The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZHuman Molecular Genetics, 2012
- NPHP4, a cilia-associated protein, negatively regulates the Hippo pathwayThe Journal of cell biology, 2011
- Altered Hippo signalling in polycystic kidney diseaseThe Journal of Pathology, 2011
- Scribble participates in Hippo signaling and is required for normal zebrafish pronephros developmentProceedings of the National Academy of Sciences of the United States of America, 2009
- Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia PhenotypeMolecular and Cellular Biology, 2003
- FAT is a component of glomerular slit diaphragmsKidney International, 2001